Pharmaceutical lobby
From Wikipedia, the free encyclopedia
The pharmaceutical lobby — also known as the drug lobby — refers to the paid representatives of large pharmaceutical and biomedicine companies in the United States who seek to influence federal government policy.
The top twenty pharmaceutical companies and their two trade groups, Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Industry Organization, lobbied on at least 1,600 pieces of legislation between 1998 and 2004. According to the non-partisan Center for Responsive Politics, pharmaceutical companies spent $900 million on lobbying between 1998 and 2005, more than any other industry. During the same period, they donated $89.9 million to federal candidates and political parties, giving approximately three times as much to Republicans as to Democrats.[1] According to the Center for Public Integrity, from January 2005 through June 2006 alone, the pharmaceutical industry spent approximately $182 million on Federal lobbying.[2] The industry has 1,274 registered lobbyists in Washington D.C. [3]
-------------------
We can only speculate that "Big Pharma" has an army of lobbyist in Washington D.C. to delay Elite from acquiring the FDA approval for its ELI-216 and other ART drugs before "Big Pharma". The emergence of high frequency traders (HFT) was by coincidence facilitated by the controversial rules and regulations passed by SEC with HFT supporters existing at high government positions. "Conspiracy Theories" leads me to suspect HFT are engaged in covert trading through alternative trading systems or "dark pools" to control the ELTP or other competitors' share prices to deny them the needed financial capital to continue with development. Just the very thought is frightening given what the power of the federal government and corruption can do for money. Its total government corruption at its best.
Cheers!
News 
Market Data 
Discover 
AI
